#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arteriosclerosis Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Oropharyngeal cancer recurrent Head and neck cancer NTRK gene fusion overexpression Bronchopulmonary aspergillosis Neuroblastoma Osteochondrodysplasia Haemophilia Cervix carcinoma Autoimmune haemolytic anaemia Huntington's disease Gestational trophoblastic tumour Acute leukaemia Transitional cell carcinoma More trials…

    Learn about Rare Diseases

    Basal cell naevus syndrome – Basic Information Primary immunodeficiency syndrome – Trials in Disease Acquired haemophilia – Life with Disease Congenital nephrogenic diabetes insipidus – Trials in Disease Hepatic angiosarcoma – Trials in Disease Hairy cell leukaemia recurrent – Life with Disease Pleomorphic leiomyosarcoma – Diagnostics Synovial sarcoma – Life with Disease Kearns-Sayre syndrome – Diagnostics Haemolytic uraemic syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    RNMB2 Soya Oil KETOROLAC TROMETAMOL Tegafur Gskvx000000017033 Linaclotide Calcium Folinate Pentahydrate Brexucabtagene Autoleucel LY3537021 Ltp001 Enalapril Maleate 68Ga-Dpi-4452 Art6043 Ceritinib OSIMERTINIB MESYLATE Dopamine Hydrochloride Transpocart19 Lixudebart Sultiame Olorofim More therapies…

    Learn about Your Condition

    Streptococcal infection Rett syndrome Malignant peritoneal neoplasm Cardiac failure congestive Post procedural complication Astrocytoma malignant Brain abscess Pertussis Hepatitis D Breast cancer metastatic Trigeminal neuralgia Cerebral haemorrhage Retinopathy of prematurity Herpes virus infection Dyspnoea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Connective tissue disorder

  • A study to evaluate the effectiveness of NAV-240 in adults with moderate-to-severe hidradenitis suppurativa

    Recruiting

    2 1 1
    Investigated Diseases:
    • Connective tissue disorder
    • Dermatitis
    • Hidradenitis
    Investigated Drugs:
    • IMB 101
    • Sodium Chloride
    Bulgaria Germany Hungary Poland Romania

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!